Charles Haddad, MD
Orthopaedic Surgery · Metairie, LANPI 1316955495
Payments from drug & device makers
Across 156 payments — averaging $36.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Amgen$289
- Medacta USA, Inc.$218
- Endo Pharmaceuticals Inc.$83
- Sanofi-aventis U.S. LLC$77
- Vericel Corporation$63
- plus $392 from 16 others
What the payments were for
- Food & beverage$5,704100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 91 | $4,581 |
| Amgen(2 entities) | 24 | $289 |
| Medacta USA, Inc. | 6 | $218 |
| Endo Pharmaceuticals Inc. | 6 | $83 |
| Sanofi-aventis U.S. LLC | 5 | $77 |
| Vericel Corporation | 3 | $63 |
| Avanos Medical | 1 | $42 |
| Heron Therapeutics, Inc. | 2 | $38 |
| Pacira Pharmaceuticals Incorporated | 2 | $38 |
| Davol Inc. | 2 | $36 |
| Bioventus LLC | 2 | $35 |
| Biocomposites Inc | 1 | $33 |
| Pacira Therapeutics, Inc. | 2 | $27 |
| Convatec Inc. | 1 | $23 |
| Zimmer Biomet | 1 | $18 |
| Organogenesis Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Baudax Bio Inc. | 1 | $16 |
| Medtronic | 1 | $13 |
| Boston Scientific | 1 | $13 |
| Globus Medical | 1 | $13 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,704 in reported general payments places this provider in the 55th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 222 | $4,187 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 149 | $1,458 |
| Diclofenac Sodium | 35 | $1,145 |
| Ondansetron OdtOndansetron | 63 | $677 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 74 | $595 |
| Ondansetron Hcl | 60 | $399 |
| Meloxicam | 157 | $386 |
| Tramadol Hcl | 103 | $300 |
| Methylprednisolone | 44 | $251 |
| Ibuprofen | 28 | $222 |
| Naproxen | 22 | $130 |
| Oxycodone Hcl | 13 | $97 |
| Gabapentin | 13 | $74 |
| Clindamycin Hcl | 22 | $63 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $24 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Metairie
- Ralph JuniusMetairie$158K
- Ryan RoubionMetairie$48K
- Keith MelanconMetairie$27K
- Pierce NunleyShreveport$3.8M
- Christopher HarrodBaton Rouge$3.1M
- Vinod DasaKenner$1.9M
- Jorge IsazaBaton Rouge$1.2M
- Robert ZuraNew Orleans$792K
- Kevin McCarthyBaton Rouge$714K
- Fernando SanchezNew Orleans$655K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.